New hope for Tough-to-Treat head and neck cancers
NCT ID NCT06006169
Summary
This study is testing two new drugs, BL-B01D1 and SI-B003, given alone and together for people with advanced head and neck cancer that has returned or spread. The main goals are to see if the treatments shrink tumors and are safe for patients. It will include about 186 adults whose cancer has worsened after previous treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, China
Contact
Contact
Conditions
Explore the condition pages connected to this study.